Wiregraph

Market coverage built from listed-company disclosures. Email [email protected] for any enquiries.

Copyright © 2025-2026 Wiregraph.com | Market data and charting by TradingView.com

BAVARIAN NORDIC

BAVA.CODK0015998017NASDAQ CopenhagenDKDKK
Stock price
BAVARIAN NORDIC
Loading chart...

Coverage

Latest articles

Nations stockpile mpox vaccine amid rising geopolitical fears
9 Jul 2025, 14:48BAVA.CONASDAQ Copenhagen

Filings

Recent filings

FilingDate
Bavarian Nordic is Planning a Rights Issue of DKK 250-300 Million. The Company Has Convened an Extraordinary General Meeting1 Dec 2009
Bavarian Nordic A/S - Notice convening Extraordinary General Meeting1 Dec 2009
Bavarian Nordic will file for market approval for IMVAMUNE® in Canada30 Nov 2009
Bavarian Nordic A/S issues Financial Calendar for 201026 Nov 2009
US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE® Smallpox Vaccine17 Nov 2009
Bavarian Nordic Enters Conditional Agreement for the Acquisition of Shares and Buy Back of Stock Options in its Subsidiary BN ImmunoTherapeutics Inc. in Order to Obtain 100% Ownership of the Subsidiary11 Nov 2009
Bavarian Nordic A/S - Interim Report for the period 1 January to 30 September 2009
Search

Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.

Bavarian Nordic sells vaccine voucher for $160 million
20 Jun 2025, 17:26BAVA.CONASDAQ Copenhagen

Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.

  • Previous
  • 1
  • 2
  • 3
  • Next
11 Nov 2009
New and interesting PROSTVAC(TM) data indicate broad therapeutic use in metastatic prostate cancer21 Sept 2009
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such18 Sept 2009
Bavarian Nordic has signed contract with an EU country for the delivery of IMVAMUNE®15 Sept 2009
Bavarian Nordic rejects claim from Helmholtz Zentrum München31 Aug 2009
Bavarian Nordic A/S - Interim Report for the period 1 January to 30 June 200928 Aug 2009
  • Previous
  • 1
  • More pages
  • 55
  • 56
  • 57
  • More pages
  • 78
  • Next
Company
BAVARIAN NORDIC
BAVA.CONASDAQ Copenhagen
Website: Unavailable
Coverage
14
Filings
927